Okay, let's tackle this question. The question is about which drug causes pulmonary fibrosis as a side effect. The correct answer was given as C. Bleomycin. Now, I need to explain this properly.

First, the core concept here is drug-induced lung toxicity. Pulmonary fibrosis is a known adverse effect of certain medications. The key is to know which drugs are associated with this.

Bleomycin is an antibiotic used in chemotherapy. It's known to cause pulmonary toxicity, leading to interstitial pneumonitis and subsequent fibrosis. The mechanism involves oxidative stress and direct damage to alveolar epithelial cells. This is a classic high-yield fact for exams.

Other options might include drugs like amiodarone, methotrexate, or cyclophosphamide. Let me think. Amiodarone can cause pulmonary toxicity too, but it's more often a non-caseating granulomatous reaction rather than fibrosis. Methotrexate is associated with interstitial pneumonitis and fibrosis but is more commonly linked with hepatotoxicity. Cyclophosphamide can cause hemorrhagic cystitis, but pulmonary fibrosis isn't its main side effect. So, the wrong options are incorrect because they don't primarily cause pulmonary fibrosis or have different mechanisms.

The clinical pearl here is to remember that bleomycin is notorious for causing pulmonary fibrosis, and monitoring with chest X-rays or CT scans is essential during treatment. Also, methotrexate can cause similar issues but is more about the liver. So, high-yield: bleomycin's pulmonary side effect is a key point in oncology.

**Core Concept**
Pulmonary fibrosis is a severe adverse effect of certain chemotherapeutic agents. **Bleomycin**, an antibiotic-derived antineoplastic drug, is notorious for causing **interstitial pneumonitis and pulmonary fibrosis** due to oxidative stress and direct alveolar epithelial cell damage.

**Why the Correct Answer is Right**
**Bleomycin** (Option C) induces pulmonary fibrosis by generating reactive oxygen species that damage lung tissue. It is particularly associated with **dose-dependent, irreversible pulmonary fibrosis**, often dose-limited in clinical use. Monitoring with chest imaging and pulmonary function tests is critical during treatment.

**Why Each Wrong Option is Incorrect**
**Option A:** **Amiodarone** causes pulmonary toxicity but primarily manifests as **non-caseating granulomas** or interstitial pneumonitis, not fibrosis.
**Option B:** **Methotrexate** can cause interstitial pneumonitis and fibrosis, but it is more commonly linked to **hepatotoxicity** and **myelosuppression**.
**Option D:** **Cyclophosphamide** is associated with **hemorrhagic cystitis** and **bladder cancer**, not pulmonary fibrosis.

**Clinical Pearl / High-Yield Fact**
Remember the pneumonic **“Bleomycin = Breathe Carefully”** to recall its pulmonary toxicity. Pulmonary fibrosis is a dose-limiting toxicity of bleomycin, requiring dose adjustments and close monitoring.

**Correct Answer: C. Bleomycin**

✓ Correct Answer: C. Bleomycin